Search

The preservation of poultry stock can be improved by incorporating therapeutic and preventive agents, including hepatoprotectors, into the diet. This study aimed to evaluate the effect of an experimental drug containing hepatoprotectors on the health of broiler chickens. The research sought to identify the potential of the preparation to enhance liver function and overall poultry stock survival. The study was conducted from 2023 to 2024 at Odesa State Agrarian University. Investigations were carried out to assess the effects of the experimental preparation in the following doses: 1.0 g/kg body weight (therapeutic dose), 2.0 g/kg body weight (double therapeutic dose), and 5.0 g/kg body weight (fivefold therapeutic dose) over 30 days. The experiment was conducted on 500 Cobb 500 broiler chickens aged 1 to 40 days. Additionally, biochemical blood parameters were measured and analysed using a Polish biochemical selective automatic analyser, the Hitachi 902. Studies have established that the optimal dose of the experimental drug for hepatosis in broiler chickens is 1.0 g/kg body weight. After administration of the drug, the serum bilirubin content decreased by 27.3%, lactate dehydrogenase activity decreased by 17.1%, aspartate aminotransferase activity decreased by 16.4%, alanine aminotransferase activity decreased by 19.3%, and vitamin A content increased by 25.6%, while the phagocytic activity of pseudoeosinophils increased by 23.1%. The results of the studies have proven that the experimental drug normalises liver function, positively affects the biochemical composition of blood, promotes growth, provides protection and natural resistance of the broiler organism, and even improves the quality of poultry products. Based on the above, it is necessary to improve methods for early diagnosis of liver function disorders in poultry and apply effective methods for correcting metabolic processes. [ABSTRACT FROM AUTHOR]

The aim: to study the pathogenicity of non-pigmented P. aeruginosa isolates compared to those that synthesize pigment during long-term storage for broiler chickens. Materials and methods. Bacteriological studies were carried out in accordance with generally accepted methods. Initially, P. aeruginosa and other bacterial microflora were isolated from poultry farms, pathological material from poultry. The type of microorganisms was identified using Bergey's identifier. The obtained isolates were examined by morphological characteristics (according to Gram), tincture, cultural, biochemical, pathogenic properties and sensitivity of selected cultures to antibiotics were studied. After the expiration of 3 years, the main biological properties of the isolates were monitored. To establish pathogenic properties, a bioassay was performed on white mice and one-week-old broiler chickens of the Cobb 500 cross (intraperitoneally by washout from daily agar culture at a dose of 0.2 cm³, which corresponds to the previously established LD50). The results. With parenteral infection by washout from agar daily culture of pigmentless isolates at a dose of LD50, chickens died within the first - second day, in this case 87.50 % of the cultures showed pathogenicity. Experimental parenteral infection with washings from a daily culture of pigmented isolates of P. aeruginosa at a dose of LD50 led to the death of one-week-old chickens within 24-48 hours, in this case 75.00 % of the isolates showed pathogenicity. Clinical and pathological signs of infection with pigmented and non-pigmented P. aeruginosa isolates were similar. Conclusions. A comparative analysis of cases of pathogenicity of non-pigmented and pigmented isolates of P. aeruginosa on one-week-old broiler chickens of the Cobb-500 cross was carried out. In the experiment, we found that among the non-pigmented isolates, compared to the pigmented pathogenic isolates, 12.5 % more were detected in chickens. This emphasizes the importance of differential diagnosis for pseudomonosis, because infection with non-pigmented strains often goes undiagnosed [ABSTRACT FROM AUTHOR]